120
Participants
Start Date
February 18, 2021
Primary Completion Date
May 24, 2021
Study Completion Date
August 30, 2021
Obicetrapib
tablets
Manassas Clinical Research Center, Manassas
Diabetes and Endocrinology Consultants, P.C., Morehead City
IACT Health, Columbus
Progressive Medical Research, Port Orange
Jacksonville Center for Clinical Research, Jacksonville
Ocala Cardiovascular Research, Ocala
Pinnacle Research Group, Anniston
Summit Research Group, LLC, Munroe Falls
Metabolic and Atherosclerosis Research Center, Cincinnati
Midwest Institute for Clinical Research, Indianapolis
Oakland Medical Research Center, Troy
Monument Health Clinical Research, Rapid City
Health Concepts, Rapid City
Lillestol Research, LLC, Fargo
Evanston Premier Healthcare Research LLC, Evanston
Juno Research, LL, Houston
National Research Institute - Wilshire, Los Angeles
National Research Institute - Huntington Park, Huntington Park
Clinical Trials Research, Sacramento
Lead Sponsor
NewAmsterdam Pharma
INDUSTRY